Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1993 Nov;61(11):4835–4841. doi: 10.1128/iai.61.11.4835-4841.1993

Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.

M L Hulse 1, S Smith 1, E Y Chi 1, A Pham 1, C E Rubens 1
PMCID: PMC281241  PMID: 8406885

Abstract

Group B streptococcal (GBS) capsular polysaccharide is an important virulence factor, and its role in invasion of cultured respiratory epithelial cells was investigated. A type III GBS clinical isolate, COH1, and asialo and unencapsulated isogenic transposon capsule mutants of it were compared in an in vitro invasion assay. The results demonstrated that capsule attenuated the invasion process. Invasion was not affected when the A549 epithelial cells were preincubated with purified type III GBS capsular polysaccharide. Polyclonal type III GBS capsule antibody inhibited invasion by COH1 but did not affect invasion by the capsule mutants. Serotypes Ia, Ib, Ia/c, II, and III all invaded respiratory epithelial cells but demonstrated some strain variation in magnitude of invasion. These observations led us to conclude that type III capsular polysaccharide was not essential for invasion of respiratory epithelial cells by GBS and that bacterial factors other than capsule were responsible for respiratory epithelial cell invasion.

Full text

PDF
4840

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craven D. E., Peppler M. S., Frasch C. E., Mocca L. F., McGrath P. P., Washington G. Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis. 1980 Oct;142(4):556–568. doi: 10.1093/infdis/142.4.556. [DOI] [PubMed] [Google Scholar]
  2. Edwards M. S., Kasper D. L., Jennings H. J., Baker C. J., Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol. 1982 Mar;128(3):1278–1283. [PubMed] [Google Scholar]
  3. Edwards M. S., Nicholson-Weller A., Baker C. J., Kasper D. L. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med. 1980 May 1;151(5):1275–1287. doi: 10.1084/jem.151.5.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gibson R. L., Lee M. K., Soderland C., Chi E. Y., Rubens C. E. Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun. 1993 Feb;61(2):478–485. doi: 10.1128/iai.61.2.478-485.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Horstmann R. D. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. Infect Immun. 1992 Mar;60(3):721–727. doi: 10.1128/iai.60.3.721-727.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Isberg R. R., Falkow S. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature. 1985 Sep 19;317(6034):262–264. doi: 10.1038/317262a0. [DOI] [PubMed] [Google Scholar]
  7. Kasper D. L. Bacterial capsule--old dogmas and new tricks. J Infect Dis. 1986 Mar;153(3):407–415. doi: 10.1093/infdis/153.3.407. [DOI] [PubMed] [Google Scholar]
  8. Martin T. R., Rubens C. E., Wilson C. B. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis. 1988 Jan;157(1):91–100. doi: 10.1093/infdis/157.1.91. [DOI] [PubMed] [Google Scholar]
  9. Martin T. R., Ruzinski J. T., Rubens C. E., Chi E. Y., Wilson C. B. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis. 1992 Feb;165(2):306–314. doi: 10.1093/infdis/165.2.306. [DOI] [PubMed] [Google Scholar]
  10. Rubens C. E., Heggen L. M., Haft R. F., Wessels M. R. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol. 1993 May;8(5):843–855. doi: 10.1111/j.1365-2958.1993.tb01631.x. [DOI] [PubMed] [Google Scholar]
  11. Rubens C. E., Heggen L. M. Tn916 delta E: a Tn916 transposon derivative expressing erythromycin resistance. Plasmid. 1988 Sep;20(2):137–142. doi: 10.1016/0147-619x(88)90016-9. [DOI] [PubMed] [Google Scholar]
  12. Rubens C. E., Raff H. V., Jackson J. C., Chi E. Y., Bielitzki J. T., Hillier S. L. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis. 1991 Aug;164(2):320–330. doi: 10.1093/infdis/164.2.320. [DOI] [PubMed] [Google Scholar]
  13. Rubens C. E., Smith S., Hulse M., Chi E. Y., van Belle G. Respiratory epithelial cell invasion by group B streptococci. Infect Immun. 1992 Dec;60(12):5157–5163. doi: 10.1128/iai.60.12.5157-5163.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Runnels P. L., Moon H. W. Capsule reduces adherence of enterotoxigenic Escherichia coli to isolated intestinal epithelial cells of pigs. Infect Immun. 1984 Sep;45(3):737–740. doi: 10.1128/iai.45.3.737-740.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. St Geme J. W., 3rd, Falkow S. Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells. Infect Immun. 1991 Apr;59(4):1325–1333. doi: 10.1128/iai.59.4.1325-1333.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wessels M. R., Haft R. F., Heggen L. M., Rubens C. E. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun. 1992 Feb;60(2):392–400. doi: 10.1128/iai.60.2.392-400.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES